Correlation Between Werewolf Therapeutics and Erasca
Can any of the company-specific risk be diversified away by investing in both Werewolf Therapeutics and Erasca at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Werewolf Therapeutics and Erasca into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Werewolf Therapeutics and Erasca Inc, you can compare the effects of market volatilities on Werewolf Therapeutics and Erasca and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Werewolf Therapeutics with a short position of Erasca. Check out your portfolio center. Please also check ongoing floating volatility patterns of Werewolf Therapeutics and Erasca.
Diversification Opportunities for Werewolf Therapeutics and Erasca
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Werewolf and Erasca is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Werewolf Therapeutics and Erasca Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Erasca Inc and Werewolf Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Werewolf Therapeutics are associated (or correlated) with Erasca. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Erasca Inc has no effect on the direction of Werewolf Therapeutics i.e., Werewolf Therapeutics and Erasca go up and down completely randomly.
Pair Corralation between Werewolf Therapeutics and Erasca
Given the investment horizon of 90 days Werewolf Therapeutics is expected to generate 0.88 times more return on investment than Erasca. However, Werewolf Therapeutics is 1.13 times less risky than Erasca. It trades about -0.12 of its potential returns per unit of risk. Erasca Inc is currently generating about -0.16 per unit of risk. If you would invest 148.00 in Werewolf Therapeutics on December 29, 2024 and sell it today you would lose (41.00) from holding Werewolf Therapeutics or give up 27.7% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Werewolf Therapeutics vs. Erasca Inc
Performance |
Timeline |
Werewolf Therapeutics |
Erasca Inc |
Werewolf Therapeutics and Erasca Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Werewolf Therapeutics and Erasca
The main advantage of trading using opposite Werewolf Therapeutics and Erasca positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Werewolf Therapeutics position performs unexpectedly, Erasca can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Erasca will offset losses from the drop in Erasca's long position.Werewolf Therapeutics vs. Monte Rosa Therapeutics | Werewolf Therapeutics vs. Design Therapeutics | Werewolf Therapeutics vs. Ikena Oncology | Werewolf Therapeutics vs. Stoke Therapeutics |
Erasca vs. Century Therapeutics | Erasca vs. Keros Therapeutics | Erasca vs. Monte Rosa Therapeutics | Erasca vs. Design Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Equity Valuation Check real value of public entities based on technical and fundamental data |